Regulatory Hurdles And Declining Demand Will Undermine Prospects

AN
AnalystLowTarget
AnalystLowTarget
Not Invested
Consensus Narrative from 16 Analysts
Published
08 Apr 25
Updated
23 Jul 25
AnalystLowTarget's Fair Value
US$143.45
14.4% overvalued intrinsic discount
23 Jul
US$164.14
Loading
1Y
43.7%
7D
0.9%

Author's Valuation

US$143.5

14.4% overvalued intrinsic discount

AnalystLowTarget Fair Value

Shared on07 May 25
Fair value Increased 5.70%

Shared on23 Apr 25
Fair value Decreased 0.32%

AnalystLowTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 1.70%

AnalystLowTarget made no meaningful changes to valuation assumptions.

Shared on10 Apr 25
Fair value Decreased 6.68%

AnalystLowTarget made no meaningful changes to valuation assumptions.